BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3297396)

  • 1. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral approaches to secondary prevention of coronary heart disease.
    Blumenthal JA; Levenson RM
    Circulation; 1987 Jul; 76(1 Pt 2):I130-7. PubMed ID: 3297396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of smoking cessation, physical training and psychological interventions in secondary prevention of coronary heart disease].
    Jost S
    Z Kardiol; 1994 Oct; 83(10):742-58. PubMed ID: 7810188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of coronary artery disease.
    Hartley LH; Foreyt JP; Alderman MH; Chesney MA; Friedman M; Hendrix GH; Herd JA; Levenson RM; Ruberman W; Thoresen CE
    Circulation; 1987 Jul; 76(1 Pt 2):I168-73. PubMed ID: 2885107
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiac rehabilitation as a first step in the secondary prevention of coronary heart disease].
    Romero T
    Rev Med Chil; 2000 Aug; 128(8):923-34. PubMed ID: 11129555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of risk factor modification through cardiac rehabilitation.
    Borrás IC; Cruz-Jiménez M; Nadal E; Middelhoff A; Rivera A
    Bol Asoc Med P R; 2008; 100(4):75-9. PubMed ID: 19400532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of nonpharmacological secondary prevention of coronary heart disease.
    Müller-Riemenschneider F; Meinhard C; Damm K; Vauth C; Bockelbrink A; Greiner W; Willich SN
    Eur J Cardiovasc Prev Rehabil; 2010 Dec; 17(6):688-700. PubMed ID: 20458247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.